Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.

Kummer MP, Vogl T, Axt D, Griep A, Vieira-Saecker A, Jessen F, Gelpi E, Roth J, Heneka MT.

J Neurosci. 2012 Dec 5;32(49):17824-9. doi: 10.1523/JNEUROSCI.1504-12.2012.

2.
3.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
4.

BACE1: the beta-secretase enzyme in Alzheimer's disease.

Vassar R.

J Mol Neurosci. 2004;23(1-2):105-14. Review.

PMID:
15126696
5.

The beta-secretase, BACE: a prime drug target for Alzheimer's disease.

Vassar R.

J Mol Neurosci. 2001 Oct;17(2):157-70. Review.

PMID:
11816789
6.

Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.

Steiner H, Capell A, Leimer U, Haass C.

Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. Review.

PMID:
10653281
7.

β-amyloid, microglia, and the inflammasome in Alzheimer's disease.

Gold M, El Khoury J.

Semin Immunopathol. 2015 Nov;37(6):607-11. doi: 10.1007/s00281-015-0518-0. Epub 2015 Aug 7. Review.

8.

The role of G protein-coupled receptors in the pathology of Alzheimer's disease.

Thathiah A, De Strooper B.

Nat Rev Neurosci. 2011 Feb;12(2):73-87. doi: 10.1038/nrn2977. Review.

PMID:
21248787
9.

The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease.

Qian M, Shen X, Wang H.

Cell Mol Neurobiol. 2016 May;36(4):471-82. doi: 10.1007/s10571-015-0232-4. Epub 2015 Jun 29. Review.

PMID:
26119306
10.

Endothelial nitric oxide: protector of a healthy mind.

Katusic ZS, Austin SA.

Eur Heart J. 2014 Apr;35(14):888-94. doi: 10.1093/eurheartj/eht544. Epub 2013 Dec 18. Review.

11.

Microglial toll-like receptors and Alzheimer's disease.

Su F, Bai F, Zhou H, Zhang Z.

Brain Behav Immun. 2016 Feb;52:187-98. doi: 10.1016/j.bbi.2015.10.010. Epub 2015 Oct 23. Review.

PMID:
26526648
12.

Innate Immunity Fights Alzheimer's Disease.

Guillot-Sestier MV, Doty KR, Town T.

Trends Neurosci. 2015 Nov;38(11):674-81. doi: 10.1016/j.tins.2015.08.008. Review.

13.

Innate immunity in Alzheimer's disease: a complex affair.

Guillot-Sestier MV, Town T.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):593-607. Review.

14.

Monocytes and Alzheimer's disease.

Feng Y, Li L, Sun XH.

Neurosci Bull. 2011 Apr;27(2):115-22. doi: 10.1007/s12264-011-1205-3. Review.

PMID:
21441973
15.

Liver X receptors: emerging therapeutic targets for Alzheimer's disease.

Sodhi RK, Singh N.

Pharmacol Res. 2013 Jun;72:45-51. doi: 10.1016/j.phrs.2013.03.008. Epub 2013 Mar 28. Review.

PMID:
23542729
16.

Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.

Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J, Fernandez F, Tan J, Shytle RD.

Mol Brain. 2011 Jun 7;4(1):23. doi: 10.1186/1756-6606-4-23. Review.

Supplemental Content

Support Center